WellCare Health Plans (NYSE:WCG) posted its quarterly earnings data on Tuesday. The company reported $4.31 EPS for the quarter, beating the Zacks’ consensus estimate of $4.16 by $0.15, Briefing.com reports. WellCare Health Plans had a net margin of 2.17% and a return on equity of 15.47%. The business had revenue of $7.01 billion for the quarter, compared to analyst estimates of $6.63 billion. During the same quarter last year, the business earned $3.69 earnings per share. The business’s revenue for the quarter was up 51.1% on a year-over-year basis.
WellCare Health Plans stock traded down $1.20 during mid-day trading on Wednesday, hitting $290.98. The company’s stock had a trading volume of 6,129 shares, compared to its average volume of 437,693. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 0.48. The firm has a market capitalization of $14.62 billion, a PE ratio of 26.41, a P/E/G ratio of 1.44 and a beta of 0.99. WellCare Health Plans has a twelve month low of $220.63 and a twelve month high of $324.99. The firm’s fifty day simple moving average is $288.32.
WCG has been the topic of a number of research analyst reports. Cantor Fitzgerald lowered shares of Castlight Health from an “overweight” rating to a “neutral” rating in a research note on Tuesday. BMO Capital Markets set a C$106.00 price objective on shares of FirstService and gave the company a “market perform” rating in a research note on Monday, June 3rd. Wells Fargo & Co reiterated a “hold” rating and set a $11.00 price objective on shares of Coty in a research note on Wednesday, May 8th. Credit Suisse Group raised their price objective on shares of JPMorgan Chase & Co. from $128.00 to $132.00 and gave the company an “outperform” rating in a research note on Monday, April 15th. Finally, Zacks Investment Research lowered shares of Genprex from a “hold” rating to a “sell” rating in a research note on Thursday, April 18th. Seven equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $315.33.
WellCare Health Plans, Inc provides government-sponsored managed care services. The company operates in three segments: Medicaid Health Plans, Medicare Health Plans, and Medicare Prescription Drug Plans (PDPs). The Medicaid Health Plans segment offers plans for beneficiaries of temporary assistance for needy families, supplemental security income, and aged blind and disabled residents; and other state-based programs, such as children's health insurance programs and long-term services and supports programs for qualifying families who are not eligible for Medicaid.
Read More: Intrinsic Value
Receive News & Ratings for WellCare Health Plans Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WellCare Health Plans and related companies with MarketBeat.com's FREE daily email newsletter.